| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| bnz-1 | interleukin-15 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia T-Cell[MeSHID:D015458] Lymphoma T-Cell Cutaneous[MeSHID:D016410] Large Granular Lymphocytic[MeSHID:D054066] |
NA | phase 2 | unknown |
| bnz-1 | interleukin-2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia T-Cell[MeSHID:D015458] Lymphoma T-Cell Cutaneous[MeSHID:D016410] Large Granular Lymphocytic[MeSHID:D054066] |
NA | phase 2 | unknown |
| bnz-1 | interleukin-9 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia T-Cell[MeSHID:D015458] Lymphoma T-Cell Cutaneous[MeSHID:D016410] Large Granular Lymphocytic[MeSHID:D054066] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||